Home / Newsroom

Newsroom

Keep up to date with the latest developments at CDISC and follow our news feeds!

As a stakeholder with an interest in the future of CDISC, you have the opportunity to participate in the process of nominating candidates for the CDISC Board of Directors. There will be two Board seats opening up with terms beginning 01 Jan 2018.

Nominations must be submitted via email to nominations@cdisc.org by 30 June 2017.

TUCSON, Ariz., and AUSTIN, Texas – June 13, 2017The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the availability of a Duchenne muscular dystrophy therapeutic area user guide (TAUG-DMD v1.0) for public review. The review period for the TAUG-DMD v1.0 began on May 8, 2017, and runs through July 6, 2017. Qualified researchers and clinicians are encouraged to review TAUG-DMD v1.0 and offer feedback.

Austin, TX – 08 June 2017 – Today, David R. Bobbitt, President and CEO at Clinical Data Interchange Standards Consortium (CDISC), appointed Shannon Labout CDISC’s Interim Chief Standards Officer. A collaborative leader, dedicated educator, and Certified Clinical Data Manager (CCDM), Ms. Labout has a proven track record of creating, leading and growing successful organizations in clinical data management, standards implementation and training. In her new role, she will guide the future of standards development, working with CDISC leadership, partners, members and volunteer teams. She will also continue to serve as CDISC’s VP of Education.

CDISC served as a key stakeholder, providing input to the development of Common Protocol Template (CPT). CPT aligns with NIH/FDA-developed Template connecting the parallel universes of clinical care and research as stated by FDA Commissioner during the CDISC/FDA strategy session in August 2016.

Austin, TX – 18 April 2017– The Clinical Data Interchange Standards Consortium (CDISC) today announced the release of Major Depressive Disorder (MDD) Therapeutic Area User Guide v1.0. The MDD standard is freely available on the CDISC website. Therapeutic Area User Guides provide research professionals with guidance on how to represent patient data in clinical research to improve quality, efficiency and cost effectiveness, enabling smarter research to unlock cures.

CDISC Contact:

Andrea Vadakin

+1.316.558.016

Austin, TX – 10 April 2017 – The Clinical Data Interchange Standards Consortium (CDISC) announced that David R. Bobbitt, MSc, MBA will join CDISC as its new Chief Executive Officer today. Mr. Bobbitt succeeds Dr. Rebecca Daniels Kush, CDISC Founder, who completed her 20-year tenure as CDISC President this month. 

CDISC Contact:

Andrea Vadakin

+1.316.558.0160

 

 

Austin, TX – 30 March 2017 – The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the participation of high-level representatives from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), the Japan Pharmaceuticals and Medical Devices Agency (PMDA), and the Infectious Diseases Data Observatory (IDDO) at the 2017 CDISC Europe Interchange. Participating global regulators will provide discussion around regulatory requirements for use of the CDISC standards that went into effect at the end of last year. Also participating in the conference will be CDISC experts and innovators from industry and academia. This educational and networking conference will be held 24-28 April in London, England.